Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06115811
Other study ID # 23-021
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 15, 2024
Est. completion date September 1, 2025

Study information

Verified date January 2024
Source Massachusetts General Hospital
Contact Rachel Jimenez, MD
Phone 617-726-8651
Email RBJIMENEZ@PARTNERS.ORG
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents.


Description:

This study involves both the development of a novel learning tool, the Radiation Treatment Plan Evaluation Learning Module, as well as a pilot program to validate this tool as an effective resource to teach treatment plan review and optimization to radiation oncology residents. Stud procedures include screening for eligibility and completion of surveys and oncology examinations. Participation is expected to last about 6-8 weeks. It is expected about 20 radiation oncology resident physicians will participate in the study.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date September 1, 2025
Est. primary completion date September 1, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - The pilot program will be open to radiation oncology resident physicians that are in their PGY-2, PGY-3, or PGY-4 year. - All residents must have completed a breast cancer-specific radiation oncology rotation at least 3 months prior to enrollment in the pilot program in order to be eligible. Exclusion Criteria: -The study will not include any special populations.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Radiation Treatment Plan Evaluation Learning Tool
Web-based program comprised of a systematic, oncology treatment plan review system and learning modules. The case bank of radiation treatments plans is accessible via econtour.org.

Locations

Country Name City State
United States Massachusetts General Hospital Cancer Center Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Massachusetts General Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Objective Examination Score Analyzed with a paired samples t-test. Up to 8 weeks
Secondary Oncology Resident Confidence Rate Scored using Likert scales and analyzed with non-parametric tests. Week 1 - 8
Secondary Oncology Resident Perceived Competence Rate Scored using Likert scales and analyzed with non-parametric tests. Week 1 - 8
See also
  Status Clinical Trial Phase
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT03734952 - Postoperative Radiotherapy in Thoracic Esophageal Squamous Cell Carcinoma With Neoadjuvant Chemoradiotherapy N/A
Recruiting NCT05176964 - Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer
Recruiting NCT03466424 - Short-course Radiotherapy (5×6Gy/7Gy/8Gy) Followed by Neo-adjuvant Chemotherapy for Locally Advanced Rectal Cancer